Accéder au contenu
Merck

Invadopodia-mediated ECM degradation is enhanced in the G1 phase of the cell cycle.

Journal of cell science (2019-09-20)
Battuya Bayarmagnai, Louisiane Perrin, Kamyar Esmaeili Pourfarhangi, Xavier Graña, Erkan Tüzel, Bojana Gligorijevic
RÉSUMÉ

The process of tumor cell invasion and metastasis includes assembly of invadopodia, protrusions capable of degrading the extracellular matrix (ECM). The effect of cell cycle progression on invadopodia has not been elucidated. In this study, by using invadopodia and cell cycle fluorescent markers, we show in 2D and 3D cultures, as well as in vivo, that breast carcinoma cells assemble invadopodia and invade into the surrounding ECM preferentially during the G1 phase. The expression (MT1-MMP, also known as MMP14, and cortactin) and localization (Tks5; also known as SH3PXD2A) of invadopodia components are elevated in G1 phase, and cells synchronized in G1 phase exhibit significantly higher ECM degradation compared to the cells synchronized in S phase. The cyclin-dependent kinase inhibitor (CKI) p27kip1 (also known as CDKN1B) localizes to the sites of invadopodia assembly. Overexpression and stable knockdown of p27kip1 lead to contrasting effects on invadopodia turnover and ECM degradation. Taken together, these findings suggest that expression of invadopodia components, as well as invadopodia function, are linked to cell cycle progression, and that invadopodia are controlled by cell cycle regulators. Our results caution that this coordination between invasion and cell cycle must be considered when designing effective chemotherapies.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Thymidine, ≥99%
Supelco
Lovastatin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Anti-TKS5 Antibody, clone 13H6.3, clone 13H6.3, from mouse